Back to search

Article

JAK-STAT Pathway Heterogeneity Governs Immunotherapy Response in Breast Cancer

2026-02-05

Abstract excerpt

The JAK-STAT pathway (JSP) is a well-known oncogenic cascade; however, recent clinical trials have detected JSP upregulation in breast cancer following anti-PD1 immunotherapy. This paradoxical observation warrants further investigation into JSP’s intercellular heterogeneity, tumor dynamics, molecular mechanisms, and clinical implications for immunotherapy. JSP expression showed dynamic shifts during breast cancer...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
7a0cfffd-e2fc-581a-a273-86c5665115d7
DOI
10.64898/2026.02.03.703506
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
JAK-STAT Pathway Heterogeneity Governs Immunotherapy Response in Breast CancerDOI 10.64898/2026.02.03.703506
Select a neighboring publication to make it the new centre.